Summary of some possible issues that have not been tested for or addressed in vaccine studies

Petition to the EU was by filed on December 1, 2020 Dr. Michael Yeadon, a former Pfizer employee and Chief scientist,
and Dr. med. Wolfgang Wodarg. They asked that the trials for the COVID19 vaccine be stopped.

Their concerns include the following:

1. Side effects when vaccine antibodies later encounter the actual virus
Antibody Dependent Enhancement (ADE) has proven to be a serious challenge with coronavirus vaccines, and
this is the primary reason many previous such vaccines have failed in early in-vitro or animal trials. For example,
rhesus macaques who were vaccinated with the Spike protein of the SARS-CoV virus demonstrated severe acute
lung injury when challenged with SARS-CoV, while monkeys who were not vaccinated did not.

ADE is when an antibody develops that does not neutralize the real virus. (which may enter the body in the
future). In some viruses, if a person harbors a non-neutralizing antibody, subsequent infection by the virus may
cause that person to elicit a more severe reaction to the virus due to the presence of the new non-neutralizing
antibody/virus conglomerate. This is a common problem with Dengue Virus, Ebola Virus, HIV, RSV, and the
family of coronaviruses.
This is a major reason past trials of coronavirus vaccines were abandoned. (Page 4, VIII)
2. Allergic, potentially deadly, reactions to polyethylene glycol (PEG)
Pfizer vaccine mRNA is coated with polyethylene glycol (PEG). Seventy percent of people make antibodies to
PEG (not related to COVID antibodies) and most do not know it, creating a concerning situation where many
could have allergic, potentially deadly, reactions to a PEG-containing vaccine (Page 5, X).

3. Possible infertility in Women

Syncytin-1, necessary in developing the mammal and human placenta has a similar sequence to spike proteins of
SARS virus. If antibodies against spike proteins in SARS (COVID19) act like antibodies to Syncytin-1 this would
then also prevent the formation of a placenta which would result in vaccinated women essentially becoming
infertile.
Note that to be eligible for the study an acceptable contraceptive method was necessary until a minimum of 28
days after the last dose of study intervention. This means that this side effect would not be seen for a long
period thereafter (Page 5, XI).

4. A bioluminescent with no known anti-viral function is an ingredient in Pfizer – it is unclear why it is included
Pfizer/BioNTech is also inserting an ingredient derived from a marine invertebrate, mNeonGreen, into its
vaccine. The ingredient has bioluminescent qualities, making it attractive for medical imaging purposes, but it is
unclear why an injected vaccine would need to have that quality. mNeonGreen has unknown
antigenicity/antibody properties (Page 5, X).

There were other issues such as

a. The high false-positive rate of PCR tests for COVID.

b. Participants were informed that the vaccine may cause fever and redness, swelling and pain at the injection site. This
would give participants who have no side effects an indication that they received the placebo. Such participants more
likely to report possible symptoms to a health care worker for a PCR test – which would negate the true randomness of
the study (Exhibits A and B).